Autism Spectrum Disorder Therapeutics Market Size, Share, Growth | Global Industry Research Report, 2018- 2025
SKU ID : FBUIN-15633986 | Publishing Date : 01-Aug-2019
Detailed TOC of Autism Spectrum Disorder Therapeutics Market Size, Share, Growth | Global Industry Research Report, 2018- 2025
TABLE OF CONTENT:1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Autism Spectrum Disorder for Key Countries/Region
4.2. Recent Industry Developments Such As Partnerships, Mergers, & Acquisitions
4.3. Regulatory Framework by Key Countries
4.4. Global Reimbursement Scenario and Economic Cost Burden for the Treatment of Autism Spectrum Disorder by Key Countries/Region
5. Global Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
5.2.1. Autistic Disorder
5.2.2. Asperger Syndrome
5.2.3. Pervasive Developmental Disorder
5.2.4. Others
5.3. Market Analysis, Insights and Forecast – By Treatment Type
5.3.1. Communication & Behavioral Therapies
5.3.1.1. Applied behavior analysis (ABA)
5.3.1.2. Speech & Language Therapy
5.3.1.3. Occupational Therapy
5.3.1.4. Others
5.3.2. Drug Therapies
5.3.2.1. Antipsychotic Drugs
5.3.2.2. SSRIS
5.3.2.3. Stimulants
5.3.2.4. Sleep Medications
5.3.2.5. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia pacific
5.4.4. Latin America
5.4.5. Middle East & Africa
6. North America Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Type
6.2.1. Autistic Disorder
6.2.2. Asperger Syndrome
6.2.3. Pervasive Developmental Disorder
6.2.4. Others
6.3. Market Analysis – By Treatment Type
6.3.1. Communication & Behavioral Therapies
6.3.1.1. Applied behavior analysis (ABA)
6.3.1.2. Speech & Language Therapy
6.3.1.3. Occupational Therapy
6.3.1.4. Others
6.3.2. Drug Therapies
6.3.2.1. Antipsychotic Drugs
6.3.2.2. SSRIS
6.3.2.3. Stimulants
6.3.2.4. Sleep Medications
6.3.2.5. Others
6.4. Market Analysis – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Type
7.2.1. Autistic Disorder
7.2.2. Asperger Syndrome
7.2.3. Pervasive Developmental Disorder
7.2.4. Others
7.3. Market Analysis – By Treatment Type
7.3.1. Communication & Behavioral Therapies
7.3.1.1. Applied behavior analysis (ABA)
7.3.1.2. Speech & Language Therapy
7.3.1.3. Occupational Therapy
7.3.1.4. Others
7.3.2. Drug Therapies
7.3.2.1. Antipsychotic Drugs
7.3.2.2. SSRIS
7.3.2.3. Stimulants
7.3.2.4. Sleep Medications
7.3.2.5. Others
7.4. Market Analysis – By Country/Sub-region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Italy
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Type
8.2.1. Autistic Disorder
8.2.2. Asperger Syndrome
8.2.3. Pervasive Developmental Disorder
8.2.4. Others
8.3. Market Analysis – By Treatment Type
8.3.1. Communication & Behavioral Therapies
8.3.1.1. Applied behavior analysis (ABA)
8.3.1.2. Speech & Language Therapy
8.3.1.3. Occupational Therapy
8.3.1.4. Others
8.3.2. Drug Therapies
8.3.3. Antipsychotic Drugs
8.3.3.1. SSRIS
8.3.3.2. Stimulants
8.3.3.3. Sleep Medications
8.3.3.4. Others
8.4. Market Analysis – By Country/Sub-region
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Latin America Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Type
9.2.1. Autistic Disorder
9.2.2. Asperger Syndrome
9.2.3. Pervasive Developmental Disorder
9.2.4. Others
9.3. Market Analysis – By Treatment Type
9.3.1. Communication & Behavioral Therapies
9.3.1.1. Applied behavior analysis (ABA)
9.3.1.2. Speech & Language Therapy
9.3.1.3. Occupational Therapy
9.3.1.4. Others
9.3.2. Drug Therapies
9.3.2.1. Antipsychotic Drugs
9.3.2.2. SSRIS
9.3.2.3. Stimulants
9.3.2.4. Sleep Medications
9.3.2.5. Others
9.4. Market Analysis – By Country/Sub-region
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
10. Middle East & Africa Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis – By Type
10.2.1. Autistic Disorder
10.2.2. Asperger Syndrome
10.2.3. Pervasive Developmental Disorder
10.2.4. Others
10.3. Market Analysis – By Treatment Type
10.3.1. Communication & Behavioral Therapies
10.3.1.1. Applied behavior analysis (ABA)
10.3.1.2. Speech & Language Therapy
10.3.1.3. Occupational Therapy
10.3.1.4. Others
10.3.2. Drug Therapies
10.3.2.1. Antipsychotic Drugs
10.3.2.2. SSRIS
10.3.2.3. Stimulants
10.3.2.4. Sleep Medications
10.3.2.5. Others
10.4. Market Analysis – By Country/Sub-region
10.4.1. GCC Countries
10.4.2. South Africa
10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
11.5.1. Allergan
11.5.2. Q BioMed Inc
11.5.3. Hopebridge, LLC.
11.5.4. Center for Autism and Related Disorders
11.5.5. Behavior Innovations
11.5.6. Applied Behavior Consultants
11.5.7. Fusion Autism Center
11.5.8. Otsuka Holdings Co. Ltd.
11.5.9. AstraZeneca
11.5.10. Pfizer Inc.
11.5.11. Eli Lilly and Company
11.5.12. Johnson & Johnson Services, Inc.
Keyplayers in Autism Spectrum Disorder Therapeutics Market Size, Share, Growth | Global Industry Research Report, 2018- 2025
AllerganQ BioMed Inc
Hopebridge, LLC.
Center for Autism and Related Disorders.
Behavior Innovations
Applied Behavior Consultants
Fusion Autism Center
Otsuka Holdings Co. Ltd.
AstraZeneca
Pfizer Inc.
Eli Lilly and Company.
Johnson & Johnson Services, Inc.